Frank Bisignano, a veteran of Wall Street and fintech, now leads two of the U.S. government's most critical—and cumbersome—agencies, applying a private-sector playbook to modernize operations affecting millions of Americans.
As Arrowhead Pharmaceuticals' stock skyrockets following its first FDA approval, one investment fund has taken profits, trimming a multimillion-dollar stake while maintaining a significant position in the high-flying biotech.
Atkore International Group Inc. (NYSE: ATKR) reported first-quarter earnings that exceeded expectations, driven by robust demand in its core electrical segment and significant productivity gains. The company reaffirmed its fiscal 2026 outlook while detailing progress on its strategic 80/20 initiative, including the divestiture of non-core assets and the planned consolidation of manufacturing facilities to sharpen focus on electrical infrastructure markets.
The healthcare giant's first-quarter earnings guidance falls below Wall Street estimates, with its key pediatric nutrition business continuing to face significant pressure from lost contracts and rising costs.
A discounted cash flow analysis suggests Trustpilot Group's shares are trading close to their intrinsic value. We break down the model, its assumptions, and what it means for investors in the online reviews giant.
Shares in telecom tower operator IHS Holding surged following a strong operational update, highlighted by record free cash flow margins and a significant easing of foreign exchange headwinds from Nigeria. The company also outlined strategic moves in Brazil and potential asset sales, sharpening its focus on capital efficiency.
Etsy shares face sustained pressure despite solid revenue, as diverging growth expectations and a high P/E ratio spark debate over whether the stock is a hidden gem or a value trap. We analyze the key metrics and market sentiment.
Bio-Techne's shares have rebounded to around $65, but a deep dive into valuation metrics reveals a complex picture. While a discounted cash flow model suggests the stock is near fair value, its sky-high P/E ratio tells a different story, raising questions about its long-term prospects.
Biotech firm Erasca, Inc. raised $225 million in a January 2026 follow-on equity offering, providing a substantial runway for its clinical-stage RAS-targeted cancer therapies. The capital infusion, alongside promising updates for programs like ERAS-0015 and ERAS-4001, has reignited debate on the company's valuation and path to commercialization.
Following a successful pilot in Saudi Arabia, the French luxury group and the Saudi Fashion Commission are widening their search for sustainable fashion innovators across the region, aiming to accelerate tangible solutions for the industry's environmental challenges.
Bank of America and Barclays have updated their price targets for Atmos Energy (ATO) following adjustments to long-term earnings estimates, highlighting the regulated utility's stable business model amidst a shifting economic landscape.
Shares of Soleno Therapeutics (SLNO) rallied nearly 9% after the company framed 2025 as a pivotal year, driven by the launch of its drug VYKAT XR. Despite the recent pop, the stock remains under significant pressure over the past quarter, highlighting the high-stakes bet investors are making on its commercial prospects.
As the AI race intensifies, a critical bottleneck is emerging not in processing power, but in data storage. While Nvidia grabs headlines, memory and storage providers like SanDisk and Western Digital are seeing unprecedented demand and stock surges, positioning them as the unlikely but essential kings of the current hardware cycle.
Despite trading significantly below its yearly peak, Netflix's stock is showing signs of a potential near-term recovery, according to options market data. Analysts point to a specific price target around $88 by mid-February, driven by a common trading theory, as a focal point for investors.
Mondelēz's Ritz brand returns to the Super Bowl with 'Ritz Island,' a tropical ad spot featuring Bowen Yang, Jon Hamm, and Scarlett Johansson, cementing its shift toward culturally savvy, humor-driven marketing aimed at younger audiences.
American companies are pouring more money into AI, cybersecurity, and next-gen encryption than their international peers, yet a new report reveals widespread challenges in achieving full-scale, mature deployments.
A Lancaster couple received consecutive life sentences without parole for the 2020 murders and decapitations of their two children, with surviving siblings forced to view the bodies and held captive for days.
AMD and GIGABYTE are significantly expanding their collaboration, aiming to embed advanced AI capabilities directly into consumer hardware like laptops, motherboards, and monitors, signaling a strategic push to make on-device AI a mainstream feature.
Nintendo's new Switch 2 console has achieved the fastest global launch sales in gaming history, driving record profits. However, the company's share price on the Tokyo exchange shows recent weakness, creating a disconnect between blockbuster commercial performance and near-term investor sentiment.
Snowflake's stock has tumbled nearly 30% over three months, pushing its valuation close to internal estimates and sparking debate among investors. While long-term holders remain in the green, recent momentum has faded, raising questions about its premium pricing in a competitive AI data landscape.
